InvestorsHub Logo
Followers 195
Posts 31551
Boards Moderated 3
Alias Born 04/08/2002

Re: Atlanta1 post# 1134

Tuesday, 10/18/2016 7:15:33 AM

Tuesday, October 18, 2016 7:15:33 AM

Post# of 2794
Orphan designation is expected to provide increased communication and guidance from regulators and 10-year market exclusivity should marketing authorization be obtained

- Orphan designation for Iomab-B follows SME (small or medium-sized enterprise) status, which was granted in August 2016

- Iomab-B now has orphan designation in the US and EU

$ATNM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News